Mohamed Ibrahim Elkomy is an Egyptian national working as an Analytical Development Supervisor and Packaging Development Supervisor in Saudi Arabia. He has over 10 years of experience in the pharmaceutical industry, specializing in analytical method development, validation, and stability testing. He is responsible for supervising analytical laboratories, developing and validating methods, executing stability studies, and ensuring compliance with cGMP guidelines. He also leads packaging development activities including material specification preparation and validation.
This is a free module from my course ISTQB CTAL Technical Test Analyst revised to 2012 syllabus. If you need full training feel free to contact me by email (amraldo@hotmail.com) or by mobile (+201223600207).
Technology transfer in pharmaceutical industryRakesh Wani
Evaluation and optimization Anti-hypertensive drug product by using technology transfer approaches from Research and development to manufacturing site.
This is a free module from my course ISTQB CTAL Technical Test Analyst revised to 2012 syllabus. If you need full training feel free to contact me by email (amraldo@hotmail.com) or by mobile (+201223600207).
Webinar validation of pharmaceutical manufacturing processesDr. Ganesh Prasad
This is a one hour presentation on the recent concepts of pharmaceutical manufacturing process validation in line with the 2011 FDA and EMA guidelines.
This is a free module from my course ISTQB CTAL Technical Test Analyst revised to 2012 syllabus. If you need full training feel free to contact me by email (amraldo@hotmail.com) or by mobile (+201223600207).
Technology transfer in pharmaceutical industryRakesh Wani
Evaluation and optimization Anti-hypertensive drug product by using technology transfer approaches from Research and development to manufacturing site.
This is a free module from my course ISTQB CTAL Technical Test Analyst revised to 2012 syllabus. If you need full training feel free to contact me by email (amraldo@hotmail.com) or by mobile (+201223600207).
Webinar validation of pharmaceutical manufacturing processesDr. Ganesh Prasad
This is a one hour presentation on the recent concepts of pharmaceutical manufacturing process validation in line with the 2011 FDA and EMA guidelines.
STAG transforms the test process to enable effective product assessment and certification of product fitness for beta release, which helps protect the investment in product development for a leading Fleet Management solution provider.
Quality assurance is a wide ranging concept covering all matters that individually and collectively influence the quality of product.
It is the arrangements made with the object of ensuring that pharmaceutical products are of the quality required for the intended use.
Assurance of product quality is derived from careful attention of factors including selection of quality parts and materials, adequate product and process design, control of the process, and in-process and end-product testing.
In the last year or so the FDA and the EMA have issued new guidance/ draft guidance on "Process Validation".These align process validation activities with a product lifecycle concept and the International Conference on Harmonisation (ICH) guidances for industry, Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The earlier guidelines were developed before the elaboration of the new ICH guidelines.With these new guidelines, additional opportunities are available to verify the control of the process by alternative means to the manufacture of traditional process validation batches. The main objective of process validation remains that a process design yields a product meeting its pre-defined quality criteria. ICH Q8, Q9 and Q10 provide a structured way to define product critical quality attributes, design space, the manufacturing process and the control strategy. ICH Q8 refers to an ‘enhanced’ approach to pharmaceutical development which includes an alternative to the traditional process validation.
Continuous process verification [see definition in ICH Q8(R2) glossary] can be utilised in process validation protocols for the initial commercial production and for manufacturing process changes for the continual improvement throughout the remainder of the product lifecycle.
There is now a new paradigm in process validation. This presentation has been prepared from material available from FDA , EMA and ICH for beginners to have an overview of the new paradigm.
Predicting an instrument's performance over time is essential to the design phase. This session will cover reliability testing and performance deterioration, including recommendations for tests that should be performed to ensure that an instrument will function through a lifetime of use, and ways to collect measurable outputs of the instrument from initial use to the end of its lifecycle.
Aliaa delivered a session in the topic of “Test planning” using a new technique of delivering content through games and knowledge sharing instead of instructive technique. The session covered all test planning activities including defining test items, risk assessment techniques, testing strategies, planning for testing resources, testing scheduling, and test deliverables and the final test plan documents.
The session introduced to quality team at ITWorx (June , 2013)
STAG transforms the test process to enable effective product assessment and certification of product fitness for beta release, which helps protect the investment in product development for a leading Fleet Management solution provider.
Quality assurance is a wide ranging concept covering all matters that individually and collectively influence the quality of product.
It is the arrangements made with the object of ensuring that pharmaceutical products are of the quality required for the intended use.
Assurance of product quality is derived from careful attention of factors including selection of quality parts and materials, adequate product and process design, control of the process, and in-process and end-product testing.
In the last year or so the FDA and the EMA have issued new guidance/ draft guidance on "Process Validation".These align process validation activities with a product lifecycle concept and the International Conference on Harmonisation (ICH) guidances for industry, Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The earlier guidelines were developed before the elaboration of the new ICH guidelines.With these new guidelines, additional opportunities are available to verify the control of the process by alternative means to the manufacture of traditional process validation batches. The main objective of process validation remains that a process design yields a product meeting its pre-defined quality criteria. ICH Q8, Q9 and Q10 provide a structured way to define product critical quality attributes, design space, the manufacturing process and the control strategy. ICH Q8 refers to an ‘enhanced’ approach to pharmaceutical development which includes an alternative to the traditional process validation.
Continuous process verification [see definition in ICH Q8(R2) glossary] can be utilised in process validation protocols for the initial commercial production and for manufacturing process changes for the continual improvement throughout the remainder of the product lifecycle.
There is now a new paradigm in process validation. This presentation has been prepared from material available from FDA , EMA and ICH for beginners to have an overview of the new paradigm.
Predicting an instrument's performance over time is essential to the design phase. This session will cover reliability testing and performance deterioration, including recommendations for tests that should be performed to ensure that an instrument will function through a lifetime of use, and ways to collect measurable outputs of the instrument from initial use to the end of its lifecycle.
Aliaa delivered a session in the topic of “Test planning” using a new technique of delivering content through games and knowledge sharing instead of instructive technique. The session covered all test planning activities including defining test items, risk assessment techniques, testing strategies, planning for testing resources, testing scheduling, and test deliverables and the final test plan documents.
The session introduced to quality team at ITWorx (June , 2013)
Paper presented at MWERA 2014.
Tindall, H. & Stuckey-Mickell, T.A. (2014). Transition to Middle School, School Culture, and Discipline History: An Exploratory Study.
The International Student Recruitment Journey - Net Natives at BUILANatives
Net Natives presented research and analysis of the international student recruitment journey to delegates at the BUILA Annual Conference 2015 in Liverpool. Delegates included directors and heads of international departments at some of the UK's top universities.
I'm Looking forward to a challenging work opportunity in your esteemed organization, where my experiences can be utilized and enriched and I can share in achieving the organization mission and strategic goals.
certificates link:
https://www.slideshare.net/AhmedShehta12/ss-250260913
A detail-oriented, sincere and hardworking individual with a Master of Science and Over Fourteen years of GLP/GMP work experience
Expert in Audit trails review in Empower, Lab solutions, Tiamo and other softwares.
Experience in theoretical and practical knowledge in calibration, preventive maintenance, troubleshooting and problem solving of critical equipment like HPLC, GC, Auto Titrator,DR and UV-Spectrophotometer etc.
1. Mohamed Ibrahim Elkomy
Date of Birth 1 Sept. -1983
Nationality Egyptian
Gender Male
Marital Status Married
Military Status Exempted
Address Saudi Arabia , AlQassim
Email Address M.elkomy@deef.com
Mobile Phone 0542546374 , 0542564581
O B J E C T I V E S
Want to improve and develop my experience in the field that I like beside my studies, in a way that
utilizes my ambitious personality toward achieving some high challenges in that field, in order to become
expert to being able to reach the most ambitious executive levels.
Total Experience years in pharmaceutical field about 10 years
Current job Analytical development supervisor (Methodology &validation and
stability) from April 2013 till now in DEEF Pharmaceutical Industries in KSA
Creating analytical methods for analysis for new products including (Assay, Related substances,
Dissolution….etc.) (qualitative and quantitative method)
Validate the new methods according to ICH guideline
Developed the old analytical method for decrease the time for analysis and enhancing system
suitability and separations then validate it according to ICH guideline
Execute and planning for stability samples for scale up batches according to GCC guidelines for
stability.
Compilation for stability data and doing trend analysis for the results
Prepare Stability summary ,stability approval and commitment letter required for eCTD
Sharing in Investigation for OOS for finished product and stability samples.
Prepare, revise and establish GTP, SOPs and STPs regarding to quality section.
Leading the analytical method transfer between external laboratory and Quality control laboratory.
Execute and supervise calibration and verification for these instruments potency analysis (HPLC,
GC, UV,) and physicochemical analysis AA, IR, PH, Viscometer, Conductivity Meter, Polarimeter,
Karl Fischer Apparatus, Dissolution Tester, Disintegration, Friability apparatus and Hardness
Tester, TOC, Melting Point Tester
Review process validation protocols and report and ensure all developing projects, initiatives, and
processes are in conformance with local and international guidelines.
Supervises the investigation of results and minimizes laboratory errors.
Support the product registration/dossier compilation activities.
Finding solution for troubleshooting in analytical laboratory including instruments
troubleshooting and the methods problems
Prepare analytical quality part in module 3 and in module 2 in eCTD and upload to Docubridge
system also answering 1.9 Responses to questions from SFDA and GCC Countries.
2. Updating, creating and trains for the report and results by custom field in empower software.
Prepare protocols for stability studies and analytical method validation, cleaning and process
validation.
Follow up the instrument routine maintenance by its agent and create the needful from new
instruments that we need.
Reviews validation of test methods are validated by QC members after receiving from R&D.
Conducts all administrative duties including regulation of work hours, work shifts, overtime, etc.
Ensures that qualified, skilled, and trained personnel and other resources are available
Provides technical expertise in support of the development of Q.C. testing methods & material
specifications.
Review TDP for technology transfer from external laboratory.
Provides feedback and evaluations as needed and required
Monitors training plan and matrix as required ensuring compliance and staff proficiency.
Assists management of critical laboratory programs such as internal quality control program,
measurement of uncertainty.
Directs, through intermediate personnel, workers engaged in inspection and testing activities to
ensure continuous control over materials and products
Reviews and evaluates all data generated by different operations and quality control department
and accordingly release or reject the raw & packaging materials
Plans, coordinates, and directs quality control program, designed to ensure continuous production
of products consistent with established standards.
Develops and analyzes statistical data and product specifications to determine present standards
and establish proposed quality and reliability expectancy of finished product.
From January 2014 added to me the responsibilities of Packaging development
Preparation of packaging material specification, standard testing procedures of primary packaging
material as per BP/ USP/ Indian standard method and secondary packaging material as per in-
house method.
Leading the track and trace project in Deef company and responsible about its implementation.
Packaging development of new products, which involves feasibility studies, various tests for new
packaging materials to minimize risk and updating of packaging development in existing products.
Preparing packaging bill of material records.
Create the code system for all items in deef company (finished products& Raw materials&
Packaging materials& lab accessories& lab. chemicals and general items)
Co-ordinate with different department like Documentation, Quality control, QA, Purchase,
Production and designer department etc. for developing the artwork and constant supply of
packaging component as per the requirement of marketing department.
Working for cost reduction project of packaging material.
Work with R&D to identify/develop packaging components for new pharmaceutical products.
Responsible for providing expert technical support for the development, procurement and
troubleshooting of Packaging materials and components to support Site Packaging operations.
Prepare container closure systems report in module 3 and in module 2 in eCTD and upload to
Docubridge system
Ensures that Packaging-related Documentation (component specifications, BOM, and Packaging
Instructions) is maintained within compliance specifications. Preparation of artworks and
approval for the same
Extensive experience with blister packaging components and process
3. Formulation development and registration experience
Preparing and justification for specification of finished goods (FS, IS, SS) and upload to
Docubridge system.
Preparing and execute comparative study between brand and generic product, Perform
incompatibility study for R&D product.
Trained on DocuBridge software and can work on it
Prepare technical files required for eCTD submission and upload to DocuBridge.
Response to the inquiries received from authority and reviews the answer of all related parts.
prepare related profile for the generic products and brand products and responsible about stress
testing study.
Quality control Supervisor (Finished product and stability) from October 2010 – April 2013
Supervise the lab work in stability and finish product sections
Create protocols and reports for analytical method validation
Perform cleaning validation, protocol and reports and non-routine validation
Perform verification for empower software, calibration for glassware, calibration for all HPLC
Create plan for stability analysis every month, Follow up the analysis and reviewing analysis and all
log books register by the stuff.
Responsible about stability study for second part (Actavis product)
Create, review, and revise Standard Operating Procedures (SOPs), Quality Control Deviation
Reports (QCDRs), controlled forms, and worksheets for the QC laboratory.
Perform comparison evaluation of in-house methods and current USP monographs and submit
equivalency report once testing has been completed.
Supervise in the operation and qualification of the new laboratory equipment.
Perform initial phase training for new employees of the QC lab, Initial training for new SOPs and
revised SOPs.
Standardize in house working standards, Keep reference and working standards.
Manage the Quality Control instrument calibration program, as well as the hardware and
software associated with the instruments.
Assesses the performance of QC Staff, recommends further training and practice to enhance their
competency.
Quality Control Senior ( Finished and stability) from May 2008 – October 2010
Perform complete analysis for IPC samples, finished product samples and stability samples.
Monitor stability samples at the predefined conditions and withdrawal it according to plan.
Create computerized form for record of analysis and report of analysis for finished product and
certificate of analysis.
Implement all types of stability studies (Accelerated, intermediate, long term and after
reconstitution)
Create Standard test procedures (STPS) for finished Product and validate it.
Finish product Specialist from January 2006 – May 2008 (Delta pharma in
Egypt)
Perform routine analysis of IPC and finished products samples and cleaning validation samples
Analyze process validation samples.
Follow and preparing reagent solutions and other analytical requirements.
4. Analyze cleaning and process validation samples.
Perform physical & chemical analysis using wet chemistry methods and instrumentations including
HPLC, GC,AA,IR etc
Implement environmental, health and safety (EHS) in the laboratory.
E D U C A T I O N
Zagazig University-Faculty of Science.
Specialization: Special Chemistry.
Grade: Good (74.99%)
I T S K I L L S
Computer skills: Microsoft word, Excel, SAP and Internet application
International Computer Driving license (ICDL). From UCO at 23-08-2008
L A N G U A G E
Arabic: Mother tongue
English: V. Good
P E R S O N A L S K I L L S
Hard worker and able to learn new tasks quickly.
Ability to work independently or in a team.
Good planning skills.
Achieving work in time.
Good communication and presentation skills.
Able to work under pressure, Attention to details, Team player with ability to work cooperatively
and productively with stuff inside and outside of the department.
KSA experience
T R A I N I N G & C E R T I F I C A T E S
Training on software for eCTD compilation (Lorenz DocuBridge).
Training on "Testo saveris" system for Environmental monitoring system. 09-2012
Training on Agilent 7890 GC hardware and chemstation. 06-2012
Training on atomic absorption spectrophotometer (Shimadzu AA7000) 10-2011
Training by WATERS on HPLC Empower 3 software and customer field 09-2011
Tablet & Capsule manufacturing QC/QA challenges workshop. (Riyadh, 16th -18th Jan 2011).
Training on HPLC conducted by WATERS.
Training on AA conducted by Shimadzu.
HPLC (fundamental, method development and validation) sponsored by Pharmex group.
Training on Dubai on UPLC and HPLC fundamental basis and empower software
R E F E R E N C E S
To be furnished upon request.